March 17, 2026
America February 23, 2026
Generate Biomedicines, a Massachusetts-based biotech leveraging an AI-powered discovery platform to “program biology” for breakthrough therapeutics, filed Monday with U.S.…
America February 10, 2025
Biotechnology company Omega Therapeutics hit Chapter 11 bankruptcy in Delaware on Monday, listing more than $140 million in debt on…
America July 30, 2024
GlaxoSmithKline announced Monday it will invest up to $7.2 billion in a biotech venture capital firm’s research and development pipeline,…
